Price $21.84 |
Market Cap
140.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
7.4
|
P/B
1.26
|
P/S
1.63
|
Dividend %
-
|
|
P/CF
15.2
|
P/FCF
8.9
|
Op. Cash Flow
19.3K
|
FCF
2.3
|
|
Op. Margin
26.60%
|
Net Margin
22.50%
|
ROE
18.30%
|
ROI
25.60%
|
|
ROA
15.80%
|
EPS Growth
17.90%
|
Current Ratio
4.6
|
Debt/Equity
0.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Delcath Systems, Inc. (DCTH) | $0.08 | - | - | 2.1M | Strong Buy |
| CTD Holdings Inc (CTDH) | $0.39 | - | - | 42.4M | Strong Buy |
| Lannett Company, Inc. (LCI) | $5.81 | - | - | 232M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $1.87 | - | - | 72.7M | Strong Buy |
| PDL BioPharma Inc (PDLI) | $3.13 | - | - | 355.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
